Search Results 421-430 of 16878 for Humira

1. Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma - Mayo Clinic

   Targeted agent, such as nivolumab, may interfere with the ability of cancer cells to grow and spread by enhancing the immune system. Giving doxorubicin ...

2. A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis - Mayo Clinic

   It is hypothesized that AK002 is more effective than placebo control (alternative hypothesis) in reducing the number of eosinophils per high power field (HPF) ...

3. Prescription weight-loss drugs - Mayo Clinic

   Your healthcare professional may suggest a weight-loss medicine for you if you haven't been able to lose weight through diet and exercise and your: Body mass ...

4. Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU - Mayo Clinic

   This is a placebo and active-controlled phase 2b dose-finding study to evaluate efficacy and safety of QGE031 monthly subcutaneous injections as add-on therapy ...

5. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

   Clinical Trials · A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects ...

6. Neural Circulatory Control and SUDEP Risk. - Mayo Clinic

   About this study. The investigators believe epilepsy alters the way the body controls blood pressure, heart rate and breathing, and these changes increase ...

7. Siva K. Mulpuru - Doctors and Medical Staff - Mayo Clinic

   Search for a doctor. Siva K. Mulpuru. Cardiac Electrophysiologist; Cardiologist. Request an Appointment · Overview. Departments. Cardiovascular Medicine ...

8. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

   About this study. This phase II trial studies the side effects and how well ibrutinib works in treating patients with chronic lymphocytic leukemia who ...

9. A Phase 3, randomized, open-label, controlled study comparing the efficacy and safety of zanidatamab to trastuzumab, each in combination with physician’s choice chemotherapy, for the treatment of participants with metastatic HER2-positive breast cancer - Mayo Clinic

   Clinical Trials · A Phase 3, randomized, open-label, controlled study comparing the efficacy and safety of zanidatamab to trastuzumab, each in combination with ...

10. A Study of the Safety of Using SIC 8000 in Patients Undergoing Endoscopic Mucosal Removal of Colon Lesions Equal to or Larger Than 2 cm - Mayo Clinic

    The purpose of this study is to assess the effectiveness of SIC 8000 injected into the submucosa under polyps, adenomas, early-stage cancers or other ...